article Open AccessTop 1% cited
Intraocular pressure after intravitreal injection of triamcinolone acetonide
British Journal of Ophthalmology · 2002 · Vol. 87(1) · pp. 24–27
Jost B. Jonas✉(Heidelberg University)
Abstract
After intravitreal injections of 25 mg of triamcinolone acetonide, an IOP elevation can develop in about 50% of eyes, starting about 1-2 months after the injection. In the vast majority, IOP can be normalised by topical medication, and returns to normal values without further medication about 6 months after the injection.
Retinal Diseases and TreatmentsGlaucoma and retinal disordersRetinal and Optic ConditionsMedicineTriamcinolone acetonideIntraocular pressureOphthalmologyAcetonideCorticosteroidGlaucomaSurgery
MeSH terms
AgedAnti-Inflammatory AgentsFemaleHumansInjectionsIntraocular PressureMacular DegenerationMacular EdemaMaleMiddle AgedOcular HypertensionProspective StudiesTriamcinolone AcetonideVitreous Body
Citations
424
FWCI
49.58
field-weighted impact
References
46
Percentile
100%
vs. same field & year
Citations per year
Cited by
Intravitreal triamcinolone acetonide for exudative age related macular degeneration
British Journal of Ophthalmology · 2003 · 496 citations
References
Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema
American Journal of Ophthalmology · 2001 · 480 citations
Intravitreal triamcinolone for refractory diabetic macular edema
Ophthalmology · 2002 · 1,040 citations
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion
British Journal of Ophthalmology · 2002 · 371 citations
Intravitreal triamcinolone acetonide for exudative age related macular degeneration
British Journal of Ophthalmology · 2003 · 496 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
